Primary and metastatic hepatic carcinoid: Is there an algorithm?

Annals of Surgical Oncology

Volumn 10, Issue 10, 2003, Pages 1133-1135

  Yao, James C ^a   Vauthey, Jean Nicolas ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CARCINOID SYNDROME; COLORECTAL CANCER; CORRELATION ANALYSIS; CYTOREDUCTIVE SURGERY; DATA ANALYSIS; DISEASE ASSOCIATION; EDITORIAL; HUMAN; LIVER METASTASIS; LIVER SURGERY; LONG TERM CARE; MEDICAL ASSESSMENT; MEDICAL LITERATURE; PORTAL VEIN; STATISTICAL SIGNIFICANCE; TECHNIQUE; CANCER REGISTRY; CARCINOID; LIVER TUMOR; METASTASIS; NOTE; PATHOLOGY; PATIENT SELECTION; SURVIVAL;

ALGORITHMS; CARCINOID TUMOR; HUMANS; LIVER NEOPLASMS; PATIENT SELECTION; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 1542648506     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2003.10.906     Document Type: Editorial

References (16)

1. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-59.
2. Hassan MM, Yao JC. Increased incidence of carcinoid (C) tumors and improved survival of patients with metastases from 1973-1987 as compared to 1988-1999. Proc Am Soc Clin Oncol 2003:373.
3. Surveillance, Epidemiology, and End Results (SEER) data between 1973 and 1999, vol. 2002. Washington, DC: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, 2002.
4. 3a. Knox CD, Anderson CD, Lamps LW, Adkins RB, Pinson CW. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol 2003;10:1171-5.
5. Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 1998;187:88-92; discussion 92-3.
6. Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg 2003;138:859-66.
7. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995;169:36-42; discussion 42-3.
8. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003;197:29-37.
9. Chamberlain RS, Canes D, Brown KT, et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 2000;190:432-45.
10. McCarter MD, Fong Y. Role for surgical cytoreduction in multimodality treatments for cancer. Ann Surg Oncol 2001;8:38-43.
11. Vauthey JN, Rousseau DL Jr. Liver imaging. A surgeon's perspective. Clin Liver Dis 2002;6:271-95.
12. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002;137:675-80: discussion 80-81.
13. Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness - study in 26 patients. Radiology 2003;227:251-60.
14. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
15. Cady B, McDermott WV. Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 1985;201:204-9.
16. Moertel CG, Johnson CM, McKusick MA, et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994;120:302-9.